Clinical Trials Logo

Recurrent Paraganglioma clinical trials

View clinical trials related to Recurrent Paraganglioma.

Filter by:
  • None
  • Page 1

NCT ID: NCT01635907 Active, not recruiting - Clinical trials for Recurrent Pheochromocytoma

Dovitinib in Neuroendocrine Tumors

Start date: June 2012
Phase: Phase 2
Study type: Interventional

This study is being conducted to evaluate whether the investigational drug Dovitinib, can shrink or slow the growth of cancer in patients with certain types of neuroendocrine tumors. This study will also further evaluate the safety of this drug.